Levetiracetam Amarox

Levetiracetam, the active ingredient in Levetiracetam Amarox, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy and is widely prescribed worldwide as part of a comprehensive seizure management plan.

GNH USA supplies Levetiracetam Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution in multiple regions.

Levetiracetam is an anticonvulsant that reduces seizure activity by modulating synaptic neurotransmitter release.

Partial‑onset seizures: reduces frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy. Myoclonic seizures: diminishes sudden muscle jerks associated with myoclonic epilepsy. Adjunct therapy in refractory epilepsy: used as add‑on treatment when seizures persist despite other medications.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Irritability

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Mood changes including depression or suicidal thoughts - Blood dyscrasias such as neutropenia or thrombocytopenia

When prescribing Levetiracetam, several safety considerations should be observed. - Renal function: assess and adjust dose in patients with impaired clearance. - Psychiatric history: monitor for mood changes or aggression. - Discontinuation: avoid abrupt cessation, taper under medical supervision. - Pregnancy: use only if benefit outweighs potential risk. - Drug interactions: review concomitant medications for enzyme inducers. - Store at room temperature: keep in original packaging, protect from moisture and light.

Levetiracetam can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Carbamazepine (enzyme inducer that lowers levetiracetam levels) - Phenobarbital (induces metabolism, reducing efficacy) - Phenytoin (induces hepatic enzymes, decreasing drug exposure)

Moderate Interactions (Monitor Closely): - Valproic acid (may increase levetiracetam plasma concentrations) - Oral contraceptives (potential reduction in hormonal efficacy)